ReviewJournal of hematology & oncology2018

Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward.

Jian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.